Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04686773
What this trial is testing

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Who this might be right for
COVID-19
R-Pharm 100
Testing effectiveness (Phase 2)UnknownNCT04315480
What this trial is testing

Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis

Who this might be right for
SARS Pneumonia
Università Politecnica delle Marche 38
Large-scale testing (Phase 3)UnknownNCT04528888
What this trial is testing

Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection

Who this might be right for
Covid19SARS-CoV InfectionPneumonia, Viral+1 more
Massimo Girardis 210
Not applicableUnknownNCT04497454
What this trial is testing

Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Respiratory Distress SyndromeMechanical VentilationSARS (Severe Acute Respiratory Syndrome)
University of Sao Paulo General Hospital 128
Large-scale testing (Phase 3)Study completedNCT05679479
What this trial is testing

Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19

Who this might be right for
COVID-19
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd 108
Large-scale testing (Phase 3)Looking for participantsNCT07743580
What this trial is testing

Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Shionogi 2,000
Not applicableStudy completedNCT04723446
What this trial is testing

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva

Who this might be right for
Covid19Coronavirus
Queen Mary University of London 54
Not applicableUnknownNCT04609488
What this trial is testing

Surfactant Levels in the Lungs of COVID-19 Patients

Who this might be right for
To Assess Surfactant Levels in Lung Fluid
Zealand University Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT05531149
What this trial is testing

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Who this might be right for
Respiratory InfectionPneumoniaCommunity-acquired Pneumonia+5 more
Biotest 107
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Not applicableStudy completedNCT04681001
What this trial is testing

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Who this might be right for
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more
Marinomed Biotech AG 300
Testing effectiveness (Phase 2)Ended earlyNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 7
Not applicableUnknownNCT04834102
What this trial is testing

COVID-19 Induced Telogen Effluvium

Who this might be right for
Covid19Telogen EffluviumSARS-CoV Infection+1 more
Istanbul Medeniyet University 200
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Testing effectiveness (Phase 2)Ended earlyNCT04498377
What this trial is testing

Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
EVIVE Biotechnology 1
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableStudy completedNCT04527432
What this trial is testing

COVID-19 Health Professional Impact Study

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome
The Royal Wolverhampton Hospitals NHS Trust 1,504
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Next Page